1. Combretastatin A4 Regulates Proliferation, Migration, Invasion, and Apoptosis of Thyroid Cancer Cells via PI3K/Akt Signaling Pathway
   Weixin Liang et al, 2016, Medical Science Monitor CrossRef
2. Mechanisms of resistance to BCR–ABL TKIs and the therapeutic strategies: A review
   Ke Yang et al, 2015, Critical Reviews in Oncology/Hematology CrossRef
3. Combretastatins: More Than Just Vascular Targeting Agents?
   Lisa M. Greene et al, 2015, Journal of Pharmacology and Experimental Therapeutics CrossRef
4. Design, synthesis, and biological evaluation of 3′,4′,5′‐trimethoxy evodiamine derivatives as potential antitumor agents
   Yijiao Peng et al, 2021, Drug Development Research CrossRef
5. Genetics and tyrosine kinase inhibitors of chronic myeloid leukemia
   Bani Bandana Ganguly et al, 2019, The Nucleus CrossRef
6. Recent advances in combretastatin A-4 codrugs for cancer therapy
   Kerong Guo et al, 2022, European Journal of Medicinal Chemistry CrossRef